Results 321 to 327 of about 26,046,977 (327)
Some of the next articles are maybe not open access.

Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS).

Lancet. Infectious Diseases (Print), 2015
M. Bourlière   +26 more
semanticscholar   +1 more source

Ledipasvir and sofosbuvir in patients with genotype 1 hepatitis C virus infection and compensated cirrhosis: An integrated safety and efficacy analysis

Hepatology, 2015
K. Reddy   +22 more
semanticscholar   +1 more source

Ledipasvir‐sofosbuvir plus ribavirin for patients with genotype 1 hepatitis C virus previously treated in clinical trials of sofosbuvir regimens

Hepatology, 2015
D. Wyles   +10 more
semanticscholar   +1 more source

UGT1*1 genotyping in a Canadian Inuit population

Pharmacogenetics, 1997
G, Monaghan   +4 more
openaire   +2 more sources

Fixed-dose combination therapy with daclatasvir, asunaprevir, and beclabuvir for noncirrhotic patients with HCV genotype 1 infection.

Journal of the American Medical Association (JAMA), 2015
F. Poordad   +25 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy